HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sara López-García Selected Research

Retinaldehyde (Retinal)

1/2019Ganglion cell layer thinning in prodromal Alzheimer's disease defined by amyloid PET.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sara López-García Research Topics

Disease

8Alzheimer Disease (Alzheimer's Disease)
01/2024 - 01/2019
2Dementia (Dementias)
01/2022 - 01/2020
2Cognitive Dysfunction
01/2020 - 01/2019
1Hearing Loss (Hearing Impairment)
10/2023
1Prodromal Symptoms
01/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2019
1Prosopagnosia
01/2019
1Ganglion Cysts (Ganglion)
01/2019

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2020
4Amyloid (Amyloid Fibrils)IBA
10/2023 - 01/2019
2Apolipoproteins E (ApoE)IBA
01/2021 - 01/2019
22- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
01/2020 - 01/2019
1Retinaldehyde (Retinal)IBA
01/2019
1Deoxyglucose (2 Deoxy D glucose)IBA
01/2019
1AD 20 (AD-20)IBA
01/2019